
Congressional Testimony & Policy Brief Preparation for Medical Affairs
Draft FDA-compliant Congressional testimony and policy briefs from clinical evidence
What You Can Do
You can rapidly convert clinical trial data, regulatory submissions, and health economic evidence into Congressional testimony statements and 2-4 page policy briefs tailored to legislative audiences. The skill ensures all materials comply with FDA promotional guidance, anticipate counterarguments from opposing stakeholders, and position your organization's perspective within the broader health policy landscape—critical for advocacy on orphan drug policies, regulatory modernization, or healthcare access legislation.
Features
condenses clinical trials, real-world data, and health economic analyses into 3-5 key findings suitable for non-scientific audiences
flags language that risks FDA violations or misrepresents data, ensuring testimony meets promotional material standards
structures testimony from your chosen perspective (patient advocacy, clinician, manufacturer) with appropriate tone and framing
generates 2-4 page executive documents with problem statement, evidence summary, legislative ask, and anticipated objections
identifies opposing viewpoints and drafts preemptive rebuttals grounded in clinical evidence
translates technical language for legislative staff, committee members, and media without oversimplifying scientific claims
converts written testimony into speaking points with natural pacing, emphasis markers, and Q&A preparation
builds consistent messaging threads across multiple testimony sessions or policy briefs on related topics
Example Output
Example 1: Policy Brief Opening
Problem Statement: "Current FDA pathway for rare pediatric diseases averages 8-12 years from discovery to patient access, compared to 4-6 years in EU. This gap results in preventable disease progression for U.S. children."
Key Finding: "Our Phase 2 trial (n=47) showed 68% disease stabilization vs. 12% with standard care; long-term follow-up (24 months) demonstrated sustained benefit with median survival extension of 18 months."
Legislative Ask: "Support the Rare Disease Innovation Acceleration Act to align FDA pediatric review timelines with EMA, reducing approval lag by 40% while maintaining safety standards."
Example 2: Congressional Testimony Sound Bite
"We're not asking for faster approval—we're asking for smarter review. Our evidence shows this therapy works. The question for Congress is: should American families wait 8 years longer than European families for the same treatment? The cost of delay is measured in children's lives."
What's Included
- SKILL.md instruction file with regulatory compliance guardrails and FDA promotional material guidance:
- Congressional Testimony Template with section structure (opening statement, clinical evidence, policy solution, closing):
- Policy Brief Framework (2-4 pages) with evidence synthesis, legislative positioning, and FAQ section:
- Stakeholder Positioning Checklist distinguishing manufacturer, clinician, and patient advocacy perspectives:
- Counterargument Preparation Worksheet to identify and rebut opposing viewpoints:
- Regulatory Language Audit Checklist for FDA compliance review before submission:
Who It's For
- Medical Affairs Managers — preparing Congressional testimony and legislative advocacy materials for regulatory or healthcare access campaigns
- Regulatory Affairs Specialists — translating clinical dossiers into policy briefs for legislative staff and committee members
- Health Policy Advocates — synthesizing clinical evidence into persuasive briefs supporting specific healthcare legislation
- Government Relations Professionals — converting scientific data into Capitol Hill talking points for manufacturer or patient advocacy organizations
- Clinical Research Leaders — presenting trial outcomes to Congressional committees or legislative staff in non-technical formats
Best For
- Drafting Congressional committee testimony on drug approval timelines, orphan drug policies, or healthcare access legislation
- Creating 2-4 page policy briefs for legislative staff supporting specific healthcare bills or regulatory modernization efforts
- Synthesizing clinical trial data into evidence summaries for health policy advocacy campaigns
- Preparing regulatory narrative and talking points before Capitol Hill meetings or FDA hearing participation
- Building anticipatory rebuttals to opposing stakeholder arguments in policy advocacy materials







